List of Excipients in API METHOCARBAMOL
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing METHOCARBAMOL
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6103 | HYDROCHLORIC ACID | |
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6103 | POLYETHYLENE GLYCOL 300 | |
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6103 | SODIUM HYDROXIDE | |
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6103 | WATER | |
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6217 | HYDROCHLORIC ACID | |
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6217 | POLYETHYLENE GLYCOL 300 | |
| Hikma Pharmaceuticals USA Inc | ROBAXIN | methocarbamol | 0641-6217 | SODIUM HYDROXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing METHOCARBAMOL
Detailed excipient profiles for METHOCARBAMOL
Excipient focus: ALUMINUM OXIDE
METHOCARBAMOL drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | methocarbamol | 71205-019 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing ALUMINUM OXIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
METHOCARBAMOL drug variants containing CELLULOSE, MICROCRYSTALLINE
METHOCARBAMOL drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
METHOCARBAMOL drug variants containing COLLOIDAL SILICON DIOXIDE
METHOCARBAMOL drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
METHOCARBAMOL drug variants containing CROSCARMELLOSE SODIUM
METHOCARBAMOL drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
METHOCARBAMOL drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | methocarbamol tablets | 71205-068 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
METHOCARBAMOL drug variants containing D&C YELLOW NO. 10
METHOCARBAMOL drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE
METHOCARBAMOL drug variants containing FD&C BLUE NO. 1--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Forte Bio-Pharma | methocarbamol | 72245-873 |
| FH2 PHARMA LLC | methocarbamol | 72887-873 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing FD&C BLUE NO. 1--ALUMINUM LAKE
Excipient focus: FD&C YELLOW NO. 6
METHOCARBAMOL drug variants containing FD&C YELLOW NO. 6
METHOCARBAMOL drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
METHOCARBAMOL drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | methocarbamol | 43353-949 |
| DIRECT RX | methocarbamol | 61919-354 |
| DirectRX | methocarbamol | 61919-627 |
| Bryant Ranch Prepack | methocarbamol | 71335-0719 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
METHOCARBAMOL drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | methocarbamol | 43353-949 |
| DIRECT RX | methocarbamol | 61919-354 |
| DirectRX | methocarbamol | 61919-627 |
| Bryant Ranch Prepack | methocarbamol | 71335-0719 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROCHLORIC ACID
METHOCARBAMOL drug variants containing HYDROCHLORIC ACID
METHOCARBAMOL drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYPROPYL CELLULOSE
METHOCARBAMOL drug variants containing HYDROXYPROPYL CELLULOSE
METHOCARBAMOL drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
METHOCARBAMOL drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
METHOCARBAMOL drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
METHOCARBAMOL drug variants containing HYPROMELLOSE
METHOCARBAMOL drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
METHOCARBAMOL drug variants containing HYPROMELLOSE 2910
METHOCARBAMOL drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
METHOCARBAMOL drug variants containing HYPROMELLOSES
METHOCARBAMOL drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
METHOCARBAMOL drug variants containing LACTOSE MONOHYDRATE
METHOCARBAMOL drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
METHOCARBAMOL drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
METHOCARBAMOL drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
METHOCARBAMOL drug variants containing MAGNESIUM STEARATE
METHOCARBAMOL drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLCELLULOSE
METHOCARBAMOL drug variants containing METHYLCELLULOSE
METHOCARBAMOL drug variants not containing METHYLCELLULOSE
Excipient focus: POLYETHYLENE GLYCOL
METHOCARBAMOL drug variants containing POLYETHYLENE GLYCOL
METHOCARBAMOL drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 300
METHOCARBAMOL drug variants containing POLYETHYLENE GLYCOL 300
METHOCARBAMOL drug variants not containing POLYETHYLENE GLYCOL 300
Excipient focus: POLYETHYLENE GLYCOL 3350
METHOCARBAMOL drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Forte Bio-Pharma | methocarbamol | 72245-873 |
| FH2 PHARMA LLC | methocarbamol | 72887-873 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
METHOCARBAMOL drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | methocarbamol | 0615-8506 |
| Marlex Pharmaceuticals Inc | methocarbamol | 10135-722 |
| Aurobindo Pharma Limited | methocarbamol | 59651-340 |
| Aurobindo Pharma Limited | methocarbamol | 59651-341 |
| Granulation Technology Inc | methocarbamol | 63561-0173 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOLS
METHOCARBAMOL drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | methocarbamol | 10544-622 |
| Rebel Distributors Corp | methocarbamol | 42254-038 |
| State of Florida DOH Central Pharmacy | methocarbamol | 53808-1045 |
| DIRECT RX | methocarbamol | 61919-354 |
| Carilion Materials Management | methocarbamol | 68151-2775 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 20
METHOCARBAMOL drug variants containing POLYSORBATE 20
METHOCARBAMOL drug variants not containing POLYSORBATE 20
Excipient focus: POLYSORBATE 80
METHOCARBAMOL drug variants containing POLYSORBATE 80
METHOCARBAMOL drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
METHOCARBAMOL drug variants containing POLYVINYL ALCOHOL
METHOCARBAMOL drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
METHOCARBAMOL drug variants containing POVIDONE
METHOCARBAMOL drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
METHOCARBAMOL drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | methocarbamol | 0615-8506 |
| Marlex Pharmaceuticals Inc | methocarbamol | 10135-722 |
| Aurobindo Pharma Limited | methocarbamol | 59651-340 |
| Aurobindo Pharma Limited | methocarbamol | 59651-341 |
| Granulation Technology Inc | methocarbamol | 63561-0173 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing POVIDONE K30
Excipient focus: POVIDONE K90
METHOCARBAMOL drug variants containing POVIDONE K90
METHOCARBAMOL drug variants not containing POVIDONE K90
Excipient focus: POVIDONES
METHOCARBAMOL drug variants containing POVIDONES
METHOCARBAMOL drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
METHOCARBAMOL drug variants containing PROPYLENE GLYCOL
METHOCARBAMOL drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
METHOCARBAMOL drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | methocarbamol | 16590-981 |
| Endo Pharmaceuticals Inc | methocarbamol | 52244-429 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
METHOCARBAMOL drug variants containing SILICON DIOXIDE
METHOCARBAMOL drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
METHOCARBAMOL drug variants containing SODIUM HYDROXIDE
METHOCARBAMOL drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
METHOCARBAMOL drug variants containing SODIUM LAURYL SULFATE
METHOCARBAMOL drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
METHOCARBAMOL drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Jerome Stevens Pharmaceuticals Inc | methocarbamol and aspirin | 50564-490 |
| Sallus Laboratories LLC | methocarbamol | 69036-930 |
| Primary Pharmaceuticals Inc | methocarbamol | 72275-351 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
METHOCARBAMOL drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
METHOCARBAMOL drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
METHOCARBAMOL drug variants containing STARCH, CORN
METHOCARBAMOL drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
METHOCARBAMOL drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | methocarbamol | 43353-779 |
| Dispensing Solutions Inc | methocarbamol | 66336-063 |
| >Company | >Ingredient | >NDC |
METHOCARBAMOL drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: STEARIC ACID
METHOCARBAMOL drug variants containing STEARIC ACID
METHOCARBAMOL drug variants not containing STEARIC ACID
Excipient focus: TALC
METHOCARBAMOL drug variants containing TALC
METHOCARBAMOL drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
METHOCARBAMOL drug variants containing TITANIUM DIOXIDE
METHOCARBAMOL drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
METHOCARBAMOL drug variants containing TRIACETIN
METHOCARBAMOL drug variants not containing TRIACETIN
Excipient focus: WATER
METHOCARBAMOL drug variants containing WATER
METHOCARBAMOL drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
